For #BreastCancerAwarenessMonth, Lesley Stark is taking part in a @CR_UK seminar exploring the challenges of experiencing cancer in a personal capacity while working in cancer research. Sign up for the seminar: https://t.co/u6kbHrgoJt Read her story here: https://t.co/wbl0nAgJ10

We’re hiring! Postdoc in Computational Genomics at @EdinUni_IGC Focus: myeloma genome, structural variants, heterochromatin, multiomics Deadline: 9 July 2025, 23:59 GMT Apply here: https://t.co/zD0exFz4gi #myeloma #postdoc #genomics #bioinformatics #epigenetics #codeandkilts

For International Women's Day tomorrow, we asked some of our women scientists, including @MiraKassouf & @DrSarahGooding, to reflect on why this day is so important. #IWD2025 #InternationalWomensDay Watch:

Together with our supporter Jason we're calling for CAR-T cell treatments to be made available for #myeloma patients on the NHS. The ability to pay should never be a barrier to accessing life-changing treatments. Read more:

🚨 Do you know the key symptoms of #myeloma? 🚨 Help us spread the word by sharing this post! Early diagnosis makes all the difference. If something feels off, don't wait - talk to your GP! #BloodCancerAwarenessMonth @MyelomaUK

So lucky to work with Peter @10000Donors and his family, whose fundraising efforts are making the North East Myeloma Genome project possible! Catch us on BBC North tonight https://t.co/wRVMQxkLGN Thank you to everyone involved! @profghjackson & NuTH team, @4130chromo @NU_Cancer

Here is a thread summary of our recent paper: Evolutionarily conserved enhancer-associated features within the MYEOV locus suggest a regulatory role for this non-coding DNA region in cancer https://t.co/ujlei8tmyu @LJRussell_Lab @cabimer @nubiosciences 1/7

Here is a blog I wrote about why I feel MRD negativity should be used as a surrogate endpoint in #myeloma clinical trials. MRD as a Clinical Trial Endpoint: A Patient Perspective https://t.co/UGaiqQ5YHb #MMSM

We are looking for a new consultant colleague (10 PA, substantive NHS post). Great opportunity for anyone with an interest in myeloma who wants to join an academic centre.

Exciting update! 📢 Our newest preprint indicates that the myeloma overexpressed gene (MYEOV) may function as a CCND1 enhancer. Thank you all @danielrico_bio @LJRussell_Lab @jearcilaga @mtrevix https://t.co/lRqc3Ls9kz

https://t.co/woDY5w1FCy Sponsored walk with my myeloma support group on 13/9/23 a week before my transplant 🥵 raising money as a group for @MyelomaUK link to our just giving page above 🧡

Finally this work on chromosome 1 in myeloma has come out which sheds light on one of the major molecular variants associated with high risk disease, congratulations to everyone one involved.

How is the genomic landscape of multiple myeloma changing? At the 2023 @COMyCongress meeting, multiple myeloma specialist Dr. J. Gareth Morgan shares how the disease's mutational signatures has advanced research in the field with @VJHemOnc. Watch here:

When Jamie went for an X-ray, he didn't expect to be diagnosed with myeloma, a type of blood cancer. "I didn't know anything about that whatsoever," "If I ask 10 people [if] they know what myeloma is I'll have 10 people who say they don't know". (1/3) https://t.co/5nYFO572Bv

Congratulations to everyone involved in our latest review: https://t.co/CMsTyZFbJy . An amazing accomplishment that was led by two early career researchers in the team. Well done Dan @DanCKent, and Leti @LetiziaM24 . @danielrico_bio @AnetaMikulasova @NU_Cancer

This #FeelgoodFriday we'd like to celebrate Sarah and Kate who last weekend challenged themselves to an ocean swim and trail run to support #CancerResearch at @UniOfNewcastle They've raised £2.5k so far - what an achievement! 👏 @NU_Cancer @10000Donors

Sharing this in case it's useful: I find that students often have a hard time conceptualizing quantitative parameters in genomics and popgen Here's a cheat-sheet I put together for teaching. It's also part of a textbook I have been writing on human genetics (more on that below)

Blood cancer can affect anybody, at any age. Help now. Register, donate or spread the word about the new campaign ⬇️ #GobForGood #mmsm #myeloma #bloodcancer https://t.co/qIt25YkjRR

Nice background for understanding the impact of simple and complex structural events in MM. #ASH22